TRCT
DERM icon

Tower Research Capital (TRC)’s Journey Medical DERM Stock Holding History

Tower Research Capital (TRC)’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.7K Buy
5,889
+1,305
+28% +$7.45K ﹤0.01% 2886
2026
Q1 		$21.5K Buy
4,584
+2,115
+86% +$16.4K ﹤0.01% 3435
2025
Q4 		$19K Buy
2,469
+743
+43% +$5.83K ﹤0.01% 3133
2025
Q3 		$12.3K Buy
1,726
+1,635
+1,797% +$11.9K ﹤0.01% 3796
2025
Q2 		$653 Buy
+91
New +$629 ﹤0.01% 4969
2025
Q1 		– Sell
-2,923
Closed -$11.4K – 5298
2024
Q4 		$11.4K Buy
2,923
+2,162
+284% +$11.8K ﹤0.01% 3716
2024
Q3 		$4.3K Sell
761
-4,172
-85% -$21.5K ﹤0.01% 4596
2024
Q2 		$27.8K Sell
4,933
-105
-2% -$432 ﹤0.01% 3545
2024
Q1 		$18.5K Buy
+5,038
New +$21.9K ﹤0.01% 3067
2023
Q4 		– Sell
-1,730
Closed -$4.74K – 5963
2023
Q3 		$4.74K Sell
1,730
-2,352
-58% -$5.25K ﹤0.01% 4820
2023
Q2 		$6.49K Sell
4,082
-1,337
-25% -$2.15K ﹤0.01% 4697
2023
Q1 		$9K Sell
5,419
-2,214
-29% -$4.13K ﹤0.01% 4475
2022
Q4 		$15K Buy
7,633
+2,577
+51% +$5.1K ﹤0.01% 3408
2022
Q3 		$12K Buy
5,056
+3,021
+148% +$10.3K ﹤0.01% 4328
2022
Q2 		$8K Sell
2,035
-119
-6% -$471 ﹤0.01% 4668
2022
Q1 		$10K Buy
2,154
+1,498
+228% +$7.48K ﹤0.01% 4296
2021
Q4 		$4K Buy
+656
New +$4.75K ﹤0.01% 5292

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAIM
Punch & Associates Investment Management Edina, Minnesota $2.02B AUM 40.6% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.41B AUM 25.22% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Tower Research Capital (TRC)'s DERM Position: Q2 2026 in Review

Tower Research Capital (TRC) increased its Journey Medical (DERM) stake by 28% in Q2 2026, buying an estimated $7.45K and bringing the position to 5,889 shares worth $41.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2886.

Tower Research Capital (TRC) first reported a position in DERM in Q4 2021 and has held it in 17 quarters since. 71 funds tracked by Wall St. Rank hold DERM as of Q2 2026.

  • Tower Research Capital (TRC) held 5,889 shares of Journey Medical worth $41.7K as of Q2 2026.
  • Tower Research Capital (TRC) bought 1,305 Journey Medical shares in Q2 2026, an estimated $7.45K.
  • Journey Medical made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #2886 holding.
  • Tower Research Capital (TRC) first reported a position in Journey Medical in Q4 2021 and has held it in 17 quarters since.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.